- Treatment of Functional Hypogonadism Besides Pharmacological Substitution
-
Corona G, Rastrelli G, Morelli A, Sarchielli E, Cipriani S, Vignozzi L, Maggi M
- KMID: 2502995
- World J Mens Health.
- 2020 Jul;38(3):256-270.
- doi: 10.5534/wjmh.190061
A dichotomic distinction between “organic” and “functional” hypogonadism is emerging. The former is an irreversible condition due to congenital or “acquired” “organic” damage of the brain centers or of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
-
Corona G, Rastrelli G, Marchiani S, Filippi S, Morelli A, Sarchielli E, Sforza A, Vignozzi L, Maggi M
- KMID: 2527316
- World J Mens Health.
- 2022 Apr;40(2):165-178.
- doi: 10.5534/wjmh.210021
The real epidemiology and the possible consequences of anabolic-androgenic steroids (AAS) use still represent a very tricky task due to the difficulties in the quantification and detection of these drugs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Risks and Benefits of Late Onset Hypogonadism Treatment: An Expert Opinion
-
Corona G, Vignozzi L, Sforza A, Maggi M
- KMID: 2320839
- World J Mens Health.
- 2013 Aug;31(2):103-125.
Late-onset hypogonadism (LOH) is a syndromic condition that has a well-recognized association with sexual and reproductive failure. LOH is frequently associated with chronic conditions including cardiovascular diseases (CVD), obesity, osteoporosis,... -
- CITED
-
- Close
- SHARE
-
- Close
